Shopping Cart 0
Cart Subtotal

Akari Therapeutics Plc (AKTX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 300

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 900
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies



Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a and formation of C5b-9. The company's pipeline products include paroxysmal nocturnal hemoglobinuria, Guillain Barre Syndrome and atypical hemolytic uremic syndrome. Akari pipeline products include Coversin, Coversin LA, LTB4+C5, LTB4, LTBA LA, and bioamine inhibitors. The company operates in Switzerland, Israel, the UK and the US. Akari is headquartered in New York City, New York, the US.

Akari Therapeutics Plc Key Recent Developments

Nov 30,2018: Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin

Nov 30,2018: Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin

Nov 15,2018: Akari Therapeutics announces third quarter 2018 financial results

Sep 30,2018: Akari Therapeutics Announces New Clinical Data in Post-Transplant Thrombotic Microangiopathies Data Supports Akari s Ongoing Clinical Expansion into a Range of Orphan Autoinflammatory Diseases That Are Either Mediated by Complement C5 or Have Synchronous

This comprehensive SWOT profile of Akari Therapeutics Plc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Akari Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table Of Content


Table of Contents

Section 1-About the Company

Akari Therapeutics Plc-Key Information

Akari Therapeutics Plc-Overview

Akari Therapeutics Plc-Key Employees

Akari Therapeutics Plc-Key Employee Biographies

Akari Therapeutics Plc-Key Operational Heads

Akari Therapeutics Plc-Major Products and Services

Akari Therapeutics Plc-History

Akari Therapeutics Plc-Company Statement

Akari Therapeutics Plc-Locations And Subsidiaries

Akari Therapeutics Plc-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Akari Therapeutics Plc-Business Description

Akari Therapeutics Plc-Corporate Strategy

Akari Therapeutics Plc-SWOT Analysis

SWOT Analysis-Overview

Akari Therapeutics Plc-Strengths

Akari Therapeutics Plc-Weaknesses

Akari Therapeutics Plc-Opportunities

Akari Therapeutics Plc-Threats

Akari Therapeutics Plc-Key Competitors

Section 3-Company Financial Performance Charts

Akari Therapeutics Plc-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Figure

List of Figures

Akari Therapeutics Plc, Performance Chart

Akari Therapeutics Plc, Ratio Charts

List Of Table

List of Tables

Akari Therapeutics Plc, Key Information

Akari Therapeutics Plc, Key Ratios

Akari Therapeutics Plc, Share Data

Akari Therapeutics Plc, Major Products and Services

Akari Therapeutics Plc, History

Akari Therapeutics Plc, Key Employees

Akari Therapeutics Plc, Key Employee Biographies

Akari Therapeutics Plc, Key Operational Heads

Akari Therapeutics Plc, Other Locations

Akari Therapeutics Plc, Subsidiaries

Akari Therapeutics Plc, Key Manufacturing facilities

Akari Therapeutics Plc, Key Competitors

Akari Therapeutics Plc, SWOT Analysis

Akari Therapeutics Plc, Ratios based on current share price

Akari Therapeutics Plc, Annual Ratios

Akari Therapeutics Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Akari Therapeutics Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts